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Abstract
Host resistance to bacterial infections is thought to be dictated by host genetic factors. Infections by the natural murine
enteric pathogen Citrobacter rodentium (used as a model of human enteropathogenic and enterohaemorrhagic E. coli
infections) vary between mice strains, from mild self-resolving colonization in NIH Swiss mice to lethality in C3H/HeJ mice.
However, no clear genetic component had been shown to be responsible for the differences observed with C. rodentium
infections. Because the intestinal microbiota is important in regulating resistance to infection, and microbial composition is
dependent on host genotype, it was tested whether variations in microbial composition between mouse strains contributed
to differences in ‘‘host’’ susceptibility by transferring the microbiota of resistant mice to lethally susceptible mice prior to
infection. Successful transfer of the microbiota from resistant to susceptible mice resulted in delayed pathogen colonization
and mortality. Delayed mortality was associated with increased IL-22 mediated innate defense including antimicrobial
peptides Reg3c and Reg3b, and immunono-neutralization of IL-22 abrogated the beneficial effect of microbiota transfer.
Conversely, depletion of the native microbiota in resistant mice by antibiotics and transfer of the susceptible mouse
microbiota resulted in reduced innate defenses and greater pathology upon infection. This work demonstrates the
importance of the microbiota and how it regulates mucosal immunity, providing an important factor in susceptibility to
enteric infection. Transfer of resistance through microbial transplantation (bacteriotherapy) provides additional mechanisms
to alter ‘‘host’’ resistance, and a novel means to alter enteric infection and to study host-pathogen interactions.
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Introduction
It is well known that there are varying levels of individual
susceptibility in a mixed population to infectious agents, and
several host resistance factors have been identified in both mice
and humans that contribute to susceptibility [1]. For example, a
single genetic locus in the mouse, nramp1/SLC11A1, confers
susceptibility and resistance to murine models of typhoid,
tuberculosis, and leishmaniasis [1]. However, there are several
examples where strain variability is well known, yet few or no host
genetic factors have been identified.
Infections of food-borne pathogens, such as enteropathogenic
Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC),
cause a disturbance in the microbial niche followed by
gastrointestinal (GI) inflammation and sometimes life-threatening
diarrhea [2]. Similar to diseases in humans, Citrobacter rodentium
colonizes the GI tract of mice and induces the same characteristic
attaching and effacing (A/E) lesions and mucosal inflammation in
mouse models [3]. Severity of C. rodentium-induced infections,
including inflammation, has been shown to vary among mice of
different genetic backgrounds [3,4]. Self-limited disease with low
or no mortality frequently occurs after C. rodentium infection in
many strains of mice including NIH Swiss (NIH) and C57Bl/6,
but for C3H/HeJ (HeJ) [3] and most FVB/N mice [5], the
infection is lethal.
Adaptive immunity is needed for the control and clearance of C.
rodentium [6]; however, innate mucosal defenses including mucin
expression and antimicrobial peptides are important for its
epithelial attachment and luminal colonization [7,8]. Despite the
fact that C3H/HeJ mice appear to have functional innate
mechanisms, it remains unclear why they are quickly overcome
by this pathogen.
Recently, it has become apparent that the microbiota plays a
key role in affecting the outcome of infection, as treatment with
antibiotics or other factors that affect microbiota can change the
outcome of infection to various pathogens in an individual host
strain [9,10]. Studies have revealed that the mucosal immune
system is dynamic depending on continued microbial signaling
[11–13]. Gastrointestinal (GI) microbiota maintain equilibrium at
the mucosa by preventing pathogen adherence through the
induction of host innate immune defenses [11,14]. For example,
gut commensals have been shown to mediate IL-22 expression, a
cytokine important for controlling C. rodentium-induced enteroco-
litis in C57Bl/6 mice [15]. Segmented filamentous bacterium
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homeostasis of CD4+ T helper cells in the lamina propria, and the
induction of cytokines including IL-17 and IL-22 as well as
downstream antimicrobial peptides regenerating islet-derived 3
(Reg3)c and Reg3b [16]. Furthermore, TLR signaling through
MyD88-dependent, IL-1R- and IL-22-dependent signaling path-
ways confines infection to the mucosal surface and prevents
bacteremia [8,17–20].
Because genetic background of the host guides gut microbial
composition [21,22] and no clear genetic divergence had been
shown to explain the difference in disease severity between
different mouse strains infected with C. rodentium, we tested the role
of different microbiotas in disease resistance using microbiota
transplantation between mouse strains. We postulated that GI
microbiota specific to HeJ mice lacked essential constituents that
could protect the intestinal mucosa from C. rodentium colonization
and infection. To investigate the role of GI microbiota, we
developed a mouse model using microbiota transplantation in
non-germfree mice. Using these models, the susceptibility of HeJ
mice carrying NIH Swiss mice microbiota (HeJ-NIH) was
compared to mice of the same genetic background carrying HeJ
microbiota (HeJ-HeJ). Mouse-specific GI microbiota that influ-
enced colonization of A/E bacterial pathogens and host
susceptibility was then characterized, and shown to play a critical
role in determining the outcome of infection.
Materials and Methods
Ethics Statement
All animal experiments were performed in strict accordance
with the guidelines of the University of British Columbia Animal
Care Committee and the Canadian Council on the Use of
Laboratory Animals. The protocol was approved by the UBC
Animal Care Committee (Certificate number:A09-0168). The
mice were euthanized by CO2 asphyxiation and all efforts were
made to minimize suffering.
Mice and microbiota transplantation
Three-week-old female NIH Swiss mice (Harlan Laboratories,
Inc., Indianapolis, IN), and C3H/HeJ mice (Jackson Laboratory,
Bar Harbor, ME) were housed at the University of British
Columbia. The gut microbiota was transferred between groups of
mice by initially depleting the native microbiota with a single oral
dose of streptomycin (20 mg) 24 hours prior to transplantation.
Freshfecalpelletsfrom 3–4donormicewerecollectedandplacedin
1 mL of transfer buffer (pre-reduced sterile phosphate buffered
saline containing 0.05% cysteine HCl (Sigma-Aldrich; Missouri,
USA)) on ice. The fecal pellets were homogenized, centrifuged at
8006gfor2 minand the supernatant wascollectedanddiluted(1:3)
in transfer buffer. One hundred mL of diluted fecal supernatant was
then orally inoculated to recipient mice over the subsequent 12 days
for a total of 6 times. To control for the effect of the transfer process
a control group was always included that received transplantation
from fecal pellets of mice of the same strain.
Microbial community analysis
Fecal samples were collected fresh for determination of
microbial composition and stored at -20uC. Total DNA was
extracted using the QIAamp DNA stool kit (Qiagen, Mississauga,
ON) according to manufacturer’s instructions with the addition of
a bead-beating step. The bacterial community profile was assessed
by terminal restriction fragment length polymorphism (T-RFLP)
as previously described [23] using broad-range bacterial primers
(Table S1) that amplify variable regions V1 to V5 and restriction
digestion with HaeIII and MspI (New England Biosciences,
Beverly, MA). Using the same primer sequences as for T-RFLP,
cloning and sequencing was used to assess community composition
of a subset of samples using TOPO TA 4.0 vector and E. coli TOP
10 chemically competent cells (Invitrogen, Carlsbad, CA). Six
separate clone libraries (60-64 clones/library) were generated from
DNA pooled between mice in a cage for 2 cages for each NIH,
HeJ-NIH and HeJ groups. Sequences with an ambiguous base
were not included and tested for chimeras and deposited in
Genbank (JF837825-JF838122). Quality sequences were aligned
with the greengenes reference alignment and clustered at an
operational taxonomic unit (OTU) sequence similarity of 97% in
the MOTHUR platform [24]. Phylogenetic trees were compared
using libshuff in MOTHUR. Classification of sequences was done
using the naı ¨ve Bayesian rRNA classifier in RDP [25].
Quantification of select bacterial populations was assessed by
real-time PCR (Primers in Table S1) on an ABI7000 (Applied
Biosystems, Foster City, CA) using SYBR green qPCR mix
(Qiagen) and standard curves generated from known isolates.
C. rodentium infection
Wildtype C. rodentium, strain DBS100, was grown overnight in
Luria broth (Sigma-Aldrich; Missouri, USA) with shaking. Mice
were infected by oral administration of 5610
8 (high dose) or 5 6
10
4 CFU (low dose) by gavage 2 days after the last transfer (d14).
Host susceptibility assessment and pathogen
colonization
Mice were monitored for weight loss and other clinical signs.
Sick mice were euthanized when body weight loss was greater than
20% of the initial weight. Surviving mice were presented as a
percentage of the initial number. Pathogen load was monitored by
plating on MacConkey agar (Difco Laboratories; Michigan, USA).
Host gene expression
Quantification of gene expression was assessed in ileum samples
by real-time PCR (Primers in Table S1) on an ABI7000 (Applied
Biosystems, Foster City, CA) using SYBR green qPCR mix
(Qiagen).
Histopathology of gut inflammation and
immunohistochemistry
Formalin-fixed tissues were embedded in paraffin and 5 mm
sections were taken for histopathological and immunochemistry
analysis. Hematoxylin and eosin stained tissues were scored for
pathology in four regions including the lumen, surface epithelium,
mucosa and submucosa as previously described [26]. For
immunohistochemistry rehydrated tissue sections were blocked
with 10% normal goat serum in staining buffer (3% BSA, 0.1%
Triton X100, 0.05% Tween20) and then incubated with sheep
anti-mouse Reg3b (R&D systems) diluted 1:100 in staining buffer
overnight at 4uC. The secondary antibody, goat anti-sheep IgG
conjugated with HRP diluted 1:1000 in staining buffer was applied
for 1 h at room temperature. Finally, tissue sections were
incubated with DAB substrate (BD) for 20 min, thoroughly rinsed,
and hematoxylin counterstained. Slides were mounted with
Permount (Fisher) and viewed under light microscope. Pictures
were taken on Zeiss Axiocam and the images were obtained using
Axiocam software (Skokie, IL).
IL-22 neutralization
A monoclonal mouse anti-human IL-22 antibody or isotype
control at a dose of 100 mg (R&D Systems, Minneapolis, MN) was
Protection through Microbial Transplantation
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for 3 consecutive days beginning 2 days prior to infection and
ending on the day of infection. Mice were given the high infection
dose and monitored for weight loss as described above. Samples
were harvested from a second set of mice after 2 doses of IL-22
and isotype antibodies to determine the effects on Reg3b
expression.
Statistical analyses
The survival curves of infected mice were compared using
Kaplan-Meier analysis followed by log-rank test. Bacterial loads
and body weights were compared using two-tailed Student’s t-test.
One-way ANOVA was used for comparisons of multiple
treatments. All analyses were performed with a 95 or 99%
confidence interval using GraphPad Prism software, version 4.0.
Multivariate analysis of microbial community composition assed
by T-RFLP included non-metric multidimensional scaling (NMS)
plotting and cluster analysis using Bray-curtis metrics in R.
Significance of treatment was tested by multiple response
permutation procedure (MRPP). Mean values in text are
presented 6 standard error.
Results
NIH microbiota colonize C3H/HeJ mice after microbiota
transplantation
Before we could determine whether transplantation between
mouse strains was possible we had to determine whether
microbiotas were specific to mouse strain. Indeed the microbiota
of NIH and HeJ mice are clearly distinct (Fig. 1a). After
pretreatment with streptomycin the transfer of NIH microbiota
to HeJ mice over a period of 12 days was quite efficient. The
majority of the T-RFLP phylotypes specific to NIH mice prior to
transfer appeared in similar abundances in HeJ-NIH mice and the
fecal bacterial profiles (d14) of HeJ-NIH mice clustered tightly
with NIH mice (Fig. 1a), rather than HeJ. The microbiota of HeJ-
HeJ clustered with HeJ-Naı ¨ve mice after microbiota transplanta-
tion. Bacterial 16S rRNA gene clone libraries of variable regions
V1-V5 generated from DNA isolated from the feces (d14) of HeJ-
Naı ¨ve, NIH and HeJ-NIH provided taxonomic information of
transferred bacteria (Fig. 1b and Fig. S1 and S2). Prior to transfer
HeJ mice had a low abundance and diversity of Bacteroidetes relative
to NIH. After transfer there was increased abundance of diverse
members of the Bacteroidetes phylum, including Prevotella, Tannerella,
Bacteroides, Rikenellaceae and Barnsiella. The abundant representation
of Lachnospiraceae family in HeJ mice (48-68% of clones) fell
substantially in HeJ-NIH mice (17–22% of clones), to more closely
resemble the Lachnospiraceae population in NIH mice (2–6% of
clones). Prior to transfer, NIH and HeJ mice had only 3 OTUs
(defined at 97% similarity) in common, whereas after transfer HeJ-
NIH mice shared nearly a third (18/61) of the OTUs detected in
the clone libraries of NIH mice. While libshuff analysis of
phylogenetic trees generated from the respective clone libraries
indicated that differences remained in the communities of NIH
and HeJ-NIH mice (P=0.01), the HeJ-NIH mice were more
similar to NIH mice than they were to HeJ-Naı ¨ve mice
(P,0.0001). HeJ-NIH mice still shared 6 of 71 OTUs with HeJ-
Naı ¨ve mice, suggesting that the HeJ microbiota was not
completely displaced. Quantification of select bacterial groups by
real-time PCR confirmed an increase in members of the
Porphyromonadaceae family and decrease in Lachnospiraceae observed
in T-RFLP and clone libraries in HeJ-NIH mice (Fig. S3).
Segmented filamentous bacteria were below detection limits for T-
RFLP in fecal samples; however, qPCR revealed a shift according
to mouse-specific microbiota. Relative abundance of SFB was
0.05% and 0.15%, in HeJ-NIH and NIH-specific microbiota,
respectively, but SFB were near the limit of detection in HeJ-
specific bacterial communities.
HeJ mice carrying NIH microbiota are less susceptible to
C. rodentium infections
Once it was established that the microbiota could be transferred
between NIH and HeJ mice, it was possible to determine whether
the microbiota from resistant mice could confer resistance to
susceptible mice. Three independent experiments were performed
using high dose infection (5610
8 CFU). When mice showed
.20% weight loss from the initial body weight measured on day 1
post infection (pi), they were euthanized and the end points were
recorded for survival assessment.
C. rodentium shedding was delayed in HeJ-NIH mice as
compared to HeJ-HeJ and HeJ-Naı ¨ve mice and significantly lower
on day 3 and 5 pi (P, 0.001) (Fig. 2a). Consequently, HeJ-NIH
mice demonstrated delayed weight loss (Fig. 2b) and mortality
(Fig. 2c) (P,0.05) after high dose infection (consistent in all 3
experiments). From these results we could conclude that at least
partial resistance to C. rodentium could be transferred between
resistant and susceptible mice by microbial transplantation.
Although HeJ-NIH mice had delayed disease with the high dose
infection, they eventually succumbed to infection, suggesting that
the microbial transplantation only delayed establishment of the
infection. Since the high-dose infection may have overwhelmed
the system, we instead challenged mice with a more realistic low
infection dose (5610
4 CFU) (Fig. 2d,e,f). As expected, low dose
infection slowed the kinetics of C. rodentium infection in all HeJ
mice when compared to the results of high infection dose. After
low dose infection, HeJ-HeJ mice showed higher and more rapid
colonization of C. rodentium than HeJ-NIH mice followed by severe
weight loss by approximately 2 weeks and 3 weeks in the first and
second challenge, respectively. As a result, euthanization was
required for HeJ-HeJ mice while significant numbers of HeJ-NIH
mice survived the infection. In the first low-dose infection
experiment all mice eventually succumbed to disease, but
remarkably, in the second low-dose challenge experiment over
70% of HeJ-NIH mice were able to clear the bacterial infection
and survived, yet all HeJ-HeJ succumbed to infection. Interest-
ingly, the mean similarity of the microbiota between HeJ-NIH
mice and NIH donors, as measured by Bray-curtis metrics, was
slightly higher (68.062.1% vs 57.363.6% similarity (P,0.05)) in
the second experiment, although this was not attributable to a
single phylotype.
NIH mice carrying HeJ microbiota are more susceptible
to C. rodentium infection
To substantiate the specific protective role of the NIH
microbiota, we performed the reciprocal experiment, where the
microbiota of HeJ mice was transferred to NIH mice and
susceptibility to C. rodentium infection was assessed. The transfer
of the microbiota from HeJ mice to NIH mice was less efficient
than the transfer from NIH to HeJ (Fig. 1a). However, compared
to NIH-NIH, NIH-HeJ mice were less similar to NIH using Bray-
curtis metrics (53.861.5 vs 61.762.2% similarity (P,0.05)), which
was associated with a depletion or loss of some NIH specific
bacterial phylotypes. Of note, one species of uncultured Prevotella
(accession JF837919) was detected by T-RFLP in all mice
receiving an NIH microbiota but below detection in all mice
receiving an HeJ microbiota. In one replicate of the experiments,
SFB were not affected in NIH-HeJ mice (0.1660.04% NIH-HeJ
Protection through Microbial Transplantation
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detection in the second replicate. Although the transfer of HeJ
microbiota to NIH mice did not result in a lethal infection as seen
in HeJ mice, NIH-HeJ mice showed an increase (P,0.05) in C.
rodentium disease in all parameters measured, including coloniza-
tion, weight loss and intestinal pathology when compared to NIH-
NIH mice (Fig. 3).
Protective host defense mechanisms are activated by
NIH-specific microbiota
Because of its role in early host defense against attaching and
effacing pathogens [20], and the previously demonstrated role of
the microbiota in regulating its expression [15], we examined the
expression of IL-22 in response to microbial transfer. The NIH
microbiota colonizing in HeJ-NIH mice apparently contributed to
activation of protective mechanism as shown by increased gene
expression of IL-22, mouse Reg3b and Reg3c in the ileum
(Fig. 4a). Reg3b, which has been shown to be protective during
Gram-negative bacterial infection in gut mucosa [27], was
abundant in the mucosal epithelium of NIH and HeJ-NIH ileum,
as detected by immunohistochemistry (Fig. 4b), whereas it was
sparse in HeJ-HeJ and HeJ-Naı ¨ve mice. Conversely, the depletion
of NIH microbiota in NIH-HeJ mice was associated with reduced
expression of IL-22 and Reg3b (Fig. 4c), indicating that its
expression is dependent on continued stimulation with certain
members of the microbiota. The expression of Reg3b was rapidly
decreased (over 2-fold within 24 hours) after depletion of NIH
microbiota with streptomycin treatment (data not shown).
Microbially induced protection is IL-22 dependent
To determine whether the microbial induction of IL-22
expression prior to infection was important to the observed
protection against C. rodentium infection we used immunoneutra-
lization of IL-22. Intraperitoneal injection of anti-IL-22 antibodies
resulted in reduced Reg3b transcript (Fig. 5a), consistent with the
previously demonstrated role of IL-22 in regulating Reg3b
Figure 1. Analysis of microbial 16S rRNA gene composition indicates successful transplantation of microbiotas between mouse
strains. (a) Similarity tree using Bray Curtis metrics of bacterial 16S rRNA gene terminal restriction fragment profiles from untreated C3H/HeJ (HeJ)
and NIH Swiss (NIH) mice and HeJ or NIH mice having received oral microbial transplantation from HeJ mice (HeJ-HeJ or NIH-HeJ) or NIH mice (HeJ-
NIH or NIH-NIH). Mice receiving transplantation were from 4 separate experiments and represent multiple cages in each experiment. The number
denotes which experiment the samples were from. (b) Classification of 16S rRNA gene clone libraries at the family level generated from fecal samples
from HeJ, NIH and HeJ-NIH mice.
doi:10.1371/journal.pone.0026988.g001
Protection through Microbial Transplantation
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26988expression [20]. Immunoneutralization of IL-22 prior to high-dose
infection in HeJ-NIH mice also resulted in earlier mean mortality
(11 days) than in mice receiving isotype control (14.5 days) (Fig 5b).
Conversely, in HeJ-HeJ mice (Fig. 5c) receiving anti-IL-22
antibodies and isotype control had similar mean mortalities (13
and 12.5 days respectively). Therefore, microbial induction of IL-
22 expression and down-stream antimicrobial defenses play a role
in the observed microbiota-induced protection against C. rodentium
infection.
Protection is not transient
To determine whether the effects of microbial transplantation
were transient we bred HeJ-NIH and HeJ-HeJ mice 4 weeks after
receiving their final microbial transfer. The offspring of the HeJ-
NIH, HeJ-HeJ and HeJ mice were then examined as to whether
the protective phenotype seen in HeJ-NIH mice was maintained.
Indeed, the offspring showed consistent microbial composition and
increases in IL-22 and Reg3b expression as their parents (Fig. 6).
The offspring of HeJ-NIH mice also showed a corresponding delay
in C. rodentium colonization on days 3 and 5 after high dose
infection and a similar delay in mortality (Fig. 6).
Discussion
Bacteriotherapy is becoming an increasingly interesting avenue
for treatment of intestinal dysfunction. Substantial success has
been seen in fecal transplantation to patients suffering from
Clostridium difficile-associated diarrhea [28]. While this manuscript
was in preparation it was also shown that replacing a susceptible
C3H/HeOuJ microbiota with a resistant C57BL/6 flora conferred
protection against C. rodentium induced colitis. This response was
correlated with elevated inflammatory responses and improved
Figure 2. Mice with NIH microbiota showed reduced susceptibility to C. rodentium infection. After microbiota transplantation, mice were
challenged with 10
8 or 10
4 colony forming units (CFU) of C. rodentium. Shedding of C. rodentium, body weight loss and survival were assessed for host
susceptibility. Data is representative of three independent experiments with high infection dose (a,b,c), or two independent experiments with low
infection dose (d,e,f). HeJ-NIH mice carrying NIH microbiota had significantly lower C. rodentium shedding in feces at the early time points post
infection, delayed weight loss and mortality. Weights are represented as mean6SEM. (n=8 for each experiment).
doi:10.1371/journal.pone.0026988.g002
Figure 3. Increased C. rodentium colonization (a), weight loss (b) and intestinal pathology (c) in NIH-HeJ as compared NIH-NIH mice
after infection. Pathology was assessed in four regions including the lumen, surface epithelium, mucosa and submucosa. Data is representative of 2
independent experiments. * P,0.05 ** P,0.01 (n=8 for each experiment).
doi:10.1371/journal.pone.0026988.g003
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state was not studied and the responses were all correlative [29].
Despite these advances, this field lacks a clear understanding of
mechanisms involved in the transplantation of microbiota.
In this study we show the successful oral transfer of microbiota
between hosts of varying susceptibility resulting in protection
against C. rodentium infection through the induction of host innate
defenses, specifically IL-22, demonstrating one mechanism
through which microbial transplantation protects against intestinal
disease. It has previously been shown that the induction of IL-22
expression upon pathogen colonization is important, as IL-22
-/-
mice are more susceptible to infection [20]. However, here we
show that pre-infection levels of expression, which are dependent
on the composition of the microbiota, are also important to
pathogen success. Expression of the essential cytokine, IL-22, has
previously been shown to be mediated by the gut microbiota by
increasing intestinal NK46+ lymphocytes [15], although this was
demonstrated as a general characteristic of the microbiota.
Segmented filamentous bacteria have recently been shown to be
highly effective in inducing IL-22 expression [16], and thus the
increased colonization of SFB in HeJ-NIH mice likely contributed
to the increased expression seen here. However, SFB were not
consistently depleted in NIH mice receiving HeJ microbiota,
whereas IL-22 expression was consistently reduced. Conversely,
the consistent depletion of numerous phylotypes, particularly an
uncultured Prevotella corresponded with reduced IL-22 expression
and increased pathology in NIH-HeJ mice, although this
relationship is only correlative. Culture and further characteriza-
tion of these organisms will be necessary to substantiate a specific
IL-22 inducing role.
Figure 4. NIH microbiota induced expression of IL-22 and reg3b. Relative expression in the ileum (a) for IL22-, Reg3c-, and Reg3b-specific
mRNA in NIH Swiss (NIH), C3H/HeJ transplanted with NIH microbiota (HeJ-NIH), C3H/HeJ transplanted with HeJ-Naı ¨ve (HeJ-HeJ) and C3H/HeJ (HeJ-
Naı ¨ve) mice relative to HeJ-HeJ mice. (b) Immunostaining for Reg3b in ileal sections shows abundant peptide in ilea of NIH and HeJ-NIH mice, but not
in HeJ-HeJ and HeJ-Naı ¨ve mice. The scale bar is equal to 50 mm. Data represents mean6SEM. (c) IL-22 and Reg3b expression in NIH mice transplanted
with HeJ microbiota (NIH-HeJ) or NIH microbiota (NIH-NIH). All figures representative of two independents experiments with n=4.
doi:10.1371/journal.pone.0026988.g004
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infection (a) and survival curves of HeJ mice receiving (b) NIH microbiota or (c) HeJ microbiota after infection with C. rodentium and intraperitoneal
injection of anti-IL-22 or isotype control. (n=4).
doi:10.1371/journal.pone.0026988.g005
Figure 6. NIH microbiota and improved survival is maintained in the following generation. (a) Similarity tree using Bray Curtis metrics of
bacterial 16S rRNA gene terminal restriction fragment profiles from the offspring of untreated C3H/HeJ (HeJ) and NIH Swiss (NIH) mice and HeJ mice
having received oral microbial transplantation from HeJ mice (HeJ-HeJ) or NIH mice (HeJ-NIH). Parent mice are identified with a the letter p. (b)
Relative expression in the ileum for IL22- and Reg3b-specific mRNA in the offspring of HeJ-Naı ¨ve, HeJ-NIH and HeJ-HeJ mice (n=5). (c) Delayed
colonization and (d) mortality in the offspring of HeJ-NIH as compared to HeJ-HeJ mice (n=8).
doi:10.1371/journal.pone.0026988.g006
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The fact that HeJ mice are TLR4
-/- rules out the role of TLR4 in
the observed response [30]. While TLR4 has been shown to
contribute to colitis in response to C. rodentium infection, it was also
shown to have no effect on host defense during infection [30].
Transfer of NIH microbiota to C3H/HeOuJ mice, which have a
functional TLR4 response [30], also increased survival time upon
C. rodentium infection (data not shown).
The fact that differences in colonization were seen at the early
stages of infection supported the role of the innate rather than
adaptive immune system in the observed protection. Adaptive
immunity is needed for the control and clearance of C. rodentium
[6], however, innate mucosal defenses including mucin and
antimicrobial peptides have been shown to be important for
epithelial attachment and luminal colonization [7,8]. Although
increased Reg3b expression correlated with protection we do not
explicitly demonstrate its role here. However, the dramatic
increase in Reg3b at the protein level observed with immunohis-
tochemistry and the previously demonstrated protective effect of
Reg3b against Gram-negative bacterial infection in the gut
mucosa [20,27] would support its role. IL-22 has also been shown
to be involved in the development of IL-17-producing T-helper
cells [31] and the induction of antimicrobial molecules including
Reg3b and Reg3c [20].
As well as demonstrating a mechanism through which microbial
transfer protects the host, this is one of only a few studies
demonstrating the feasibility of orally transferring microbiotas
between animals of different genetic backgrounds. A recent study
using oral transfer of microbiota between rats reported a reduced
transfer success when antibiotics were used prior to transfer [32].
However, microbial transfer was only administered once, and at a
time point before the antibiotics would have cleared the system. In
our experience, antibiotics take a few days to clear (unpublished
observation). The highly effective transfer of bacteria between
mouse strains would not discount the use of antibiotics in
microbial transplantation models.
Consistent with previous reports indicating that microbiota are
specific to mouse strain, we found that NIH and HeJ mice had
distinct microbial populations, supporting the influence of host
genetic determinants in the selection of gut bacteria [33,34].
However, these mice were from different suppliers, and differences
in microbial composition could have been a result of environ-
mental exposure and kinship. That the transferred microbiota was
maintained along with its beneficial effects in the next generation
of HeJ-NIH mice would support the role of exposure over genetic
determinant. However, it has previously been shown that while
new bacteria can be introduced to a mouse strain for a generation,
clearance can occur through multiple generations as a result of
host genotype [35]. Therefore, it is yet unclear whether the
absence of protective microbes in HeJ mice was a consequence of
host genetics or simply environmental exposure.
That NIH-HeJ mice were not lethally susceptible to infection
would suggest that the microbiota composition does not
completely account for differences in susceptibility. Indeed, a
genetic locus has very recently been identified in C3H mice that
makes a marked contribution to susceptibility [36]. It has yet to be
determined whether this gene plays a role in shaping microbial
composition in C3H mice.
Microbial transplantation provides an excellent model to
demonstrate the role of gut microbiota in host defense mechanisms
under a similar genetic background. This study demonstrates that
the composition of the microbiota can be shifted, resulting in
improved host-protection against intestinal infection. Further
understanding of how the host acquires a microbiota that
beneficially regulates innate defense is still necessary, but indicates
that the microbiota contribute extensively to determining
individual susceptibility or resistance to infectious agents. To
promote the beneficial microbiota for maintenance of good health
using bacteriotherapy is therefore becoming an interesting avenue
in this field.
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Figure S1 Transfer of NIH microbiota resulted in an
increased diversity and abundance of Bacteroidetes in
HeJ-NIH mice. Phylogenetic tree of 16S rRNA gene clones from
the Bacteroidetes phylum generated from fecal samples from NIH
Swiss mice (NIH) (black), C3H/HeJ mice HeJ (Red) and C3H/
HeJ mice treated with NIH Swiss microbiota (HeJ-NIH) (blue).
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Figure S2 Transfer of NIH microbiota resulted in
reduced Firmicutes in HeJ-NIH mice. Phylogenetic tree of
16S rRNA gene clones from the Firmicutes phylum generated
from fecal samples from NIH Swiss mice (NIH)(black), C3H/HeJ
mice (HeJ) (Red) and C3H/HeJ mice treated with NIH Swiss
microbiota (HeJ-NIH) (blue).
(EPS)
Figure S3 Abundance of gut bacteria by qPCR. Bacterial
abundance as assessed by real-time PCR using group specific
primers in fecal samples collected from NIH Swiss (NIH), C3H/
HeJ transplanted with NIH microbiota (HeJ-NIH), C3H/HeJ
transplanted with HeJ-Naı ¨ve (HeJ-HeJ), and C3H/HeJ (HeJ-
Naı ¨ve) on day 14 of microbiota transplantation. Abundance data
was corrected relative to eubacteria (all bacteria) and presented as
mean6SEM, (n=6). Data is representative of three independent
experiments. * P,0.05 ** P,0.01.
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Table S1 Oligonucleotides for real-time PCR and
terminal restriction fragment length polymorphism (T-
RFLP)
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